Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
1.240
+0.040 (3.33%)
At close: Oct 30, 2026, 4:00 PM EDT
1.220
-0.020 (-1.61%)
After-hours: Oct 30, 2026, 5:27 PM EDT
Pluri Market Cap
Pluri has a market cap or net worth of $15.31 million as of October 30, 2026. It is the 38,697th most valuable company in the world and the 5,346th biggest in the United States. Its market cap has decreased by 50.14% in one year.
Market Cap
15.31M
Enterprise Value
42.42M
1-Year Change
-50.14%
Global Rank
Country Rank
#5,346 United States
Category
ChartMarket Cap Chart
Since December 10, 2007, Pluri's market cap has decreased from $36.10M to $15.31M, a decrease of -57.60%. That is a compound annual growth rate of -4.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 15.30M | -44.77% |
| Dec 31, 2025 | 27.70M | 16.39% |
| Dec 31, 2024 | 23.80M | -0.83% |
| Dec 29, 2023 | 24.00M | -21.82% |
| Dec 30, 2022 | 30.70M | -34.54% |
| Dec 31, 2021 | 46.90M | -74.12% |
| Dec 31, 2020 | 181.20M | 192.73% |
| Dec 31, 2019 | 61.90M | -32.20% |
| Dec 31, 2018 | 91.30M | -38.81% |
| Dec 29, 2017 | 149.20M | 28.73% |
| Dec 30, 2016 | 115.90M | 29.35% |
| Dec 31, 2015 | 89.60M | -48.86% |
| Dec 31, 2014 | 175.20M | -16.89% |
| Dec 31, 2013 | 210.80M | 15.13% |
| Dec 31, 2012 | 183.10M | 67.98% |
| Dec 30, 2011 | 109.00M | 189.89% |
| Dec 31, 2010 | 37.60M | 74.88% |
| Dec 31, 2009 | 21.50M | 532.35% |
| Dec 31, 2008 | 3.40M | -84.62% |
| Dec 31, 2007 | 22.10M | -38.78% |
| Dec 10, 2007 | 36.10M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 17.64M |
| Marker Therapeutics | 17.34M |
| Jasper Therapeutics | 17.01M |
| Citius Pharmaceuticals | 15.79M |
| NewcelX | 15.77M |
| BioCardia | 14.96M |
| Dyadic International | 14.36M |
| AEON Biopharma | 14.19M |